永鴻生技 (6936)
永鴻生技 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$116.40M, down 6.9% from a year earlier. EPS over the last four quarters totals NT$2.23.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2025-04-28
- Founded
- 2012-05-09
- Paid-in capital
- NT$728.04M
- Common shares issued
- 72,804,000
- Legal name
- 永鴻國際生技股份有限公司
- Website
- https://www.vetnostrum.com/
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$116.40M | +2.3% | -6.9% |
| 2026-08 | NT$113.81M | -21.8% | -6.2% |
Year to date: +7.3% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.54 |
| 2026 Q1 | 0.60 |
| 2025 Q4 | 0.63 |
| 2025 Q3 | 0.46 |
| 2025 Q2 | 0.20 |
| 2025 Q1 | 0.53 |
| 2024 Q4 | 0.54 |
| 2024 Q3 | 0.64 |
Last four quarters: NT$2.23
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 1.51 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 1,293 | 0.4% |
| 1,000–5,000 shares | 1,906 | 5.1% |
| 5,001–10,000 shares | 246 | 2.6% |
| 10,001–15,000 shares | 76 | 1.3% |
| 15,001–20,000 shares | 54 | 1.4% |
| 20,001–30,000 shares | 40 | 1.4% |
| 30,001–40,000 shares | 22 | 1.1% |
| 40,001–50,000 shares | 14 | 0.9% |
| 50,001–100,000 shares | 41 | 3.9% |
| 100,001–200,000 shares | 19 | 3.3% |
| 200,001–400,000 shares | 7 | 2.4% |
| 400,001–600,000 shares | 3 | 2.2% |
| 600,001–800,000 shares | 3 | 2.8% |
| 800,001–1,000,000 shares | 5 | 6.4% |
| 1,000,001+ shares | 9 | 64.8% |
TDCC data for 2026-10-16: 9 holders own more than 1,000 lots (64.8% of shares), and 1,293 hold less than one lot (0.4%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 3 | 0 | 0 | 3 |
| 2026-10-16 | 0 | 0 | 0 | 0 |
| 2026-10-15 | 2 | 0 | 0 | 2 |
| 2026-10-14 | 1 | 0 | 0 | 1 |
| 2026-10-13 | 0 | 0 | 0 | 0 |
| 2026-10-12 | -2 | 0 | 1 | -1 |
| 2026-10-08 | -6 | 0 | 0 | -6 |
| 2026-10-07 | 5 | 0 | 0 | 5 |
| 2026-10-06 | 1 | 0 | 0 | 1 |
| 2026-10-05 | 6 | 0 | 0 | 6 |
| 2026-10-02 | -1 | 0 | 0 | -1 |
| 2026-10-01 | 1 | 0 | 0 | 1 |
| 2026-09-30 | 0 | 0 | 0 | 0 |
| 2026-09-29 | -1 | 0 | 0 | -1 |
| 2026-09-24 | 3 | 0 | 0 | 3 |
| 2026-09-23 | 0 | 0 | 0 | 0 |
| 2026-09-22 | 0 | 0 | 0 | 0 |
| 2026-09-21 | -3 | 0 | 0 | -3 |
| 2026-09-18 | 5 | 0 | 1 | 6 |
| 2026-09-17 | 0 | 0 | 0 | 0 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 16 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$32.40 (2026-10-19); 52-week range NT$31.00–46.20.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.